Melanie Arzigian

539 total citations
7 papers, 419 citations indexed

About

Melanie Arzigian is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Melanie Arzigian has authored 7 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Genetics. Recurrent topics in Melanie Arzigian's work include Pluripotent Stem Cells Research (5 papers), Zebrafish Biomedical Research Applications (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Melanie Arzigian is often cited by papers focused on Pluripotent Stem Cells Research (5 papers), Zebrafish Biomedical Research Applications (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Melanie Arzigian collaborates with scholars based in United States, China and United Kingdom. Melanie Arzigian's co-authors include Zack Z. Wang, Hao Bai, Tong Chen, David T. Scadden, Ying Shao, Patrick Au, Laurence Dahéron, Dai Fukumura, Rakesh K. Jain and Yongxing Gao and has published in prestigious journals such as Blood, Nature Biotechnology and Stem Cells.

In The Last Decade

Melanie Arzigian

7 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melanie Arzigian United States 5 325 122 117 82 76 7 419
Andrew B.J. Prowse Australia 8 330 1.0× 153 1.3× 221 1.9× 63 0.8× 50 0.7× 16 472
Janet Okogbaa United States 6 283 0.9× 200 1.6× 153 1.3× 56 0.7× 92 1.2× 8 451
Rosa M. Guzzo United States 17 422 1.3× 122 1.0× 65 0.6× 153 1.9× 42 0.6× 27 688
Lin Gao United States 9 136 0.4× 103 0.8× 95 0.8× 73 0.9× 40 0.5× 16 409
April M. Craft United States 8 519 1.6× 256 2.1× 112 1.0× 107 1.3× 67 0.9× 14 716
Jonathan Rowlinson United Kingdom 9 179 0.6× 98 0.8× 47 0.4× 105 1.3× 87 1.1× 16 319
Šime Brkić Switzerland 8 222 0.7× 74 0.6× 71 0.6× 161 2.0× 94 1.2× 12 442
Shiori Katayama Japan 10 515 1.6× 313 2.6× 167 1.4× 58 0.7× 170 2.2× 14 763
Drew M. Titmarsh Australia 14 316 1.0× 148 1.2× 216 1.8× 63 0.8× 34 0.4× 17 499
Daniele Boso Italy 11 165 0.5× 104 0.9× 72 0.6× 45 0.5× 69 0.9× 13 316

Countries citing papers authored by Melanie Arzigian

Since Specialization
Citations

This map shows the geographic impact of Melanie Arzigian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Arzigian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Arzigian more than expected).

Fields of papers citing papers by Melanie Arzigian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Arzigian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Arzigian. The network helps show where Melanie Arzigian may publish in the future.

Co-authorship network of co-authors of Melanie Arzigian

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Arzigian. A scholar is included among the top collaborators of Melanie Arzigian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Arzigian. Melanie Arzigian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bai, Hao, Kang Chen, Melanie Arzigian, et al.. (2011). Bcl-xL enhances single-cell survival and expansion of human embryonic stem cells without affecting self-renewal. Stem Cell Research. 8(1). 26–37. 38 indexed citations
2.
Chen, Kang, Hao Bai, Melanie Arzigian, et al.. (2010). Endothelial cells regulate cardiomyocyte development from embryonic stem cells. Journal of Cellular Biochemistry. 111(1). 29–39. 25 indexed citations
3.
Bai, Hao, Yongxing Gao, Melanie Arzigian, et al.. (2009). BMP4 regulates vascular progenitor development in human embryonic stem cells through a smad‐dependent pathway. Journal of Cellular Biochemistry. 109(2). 363–374. 57 indexed citations
4.
Bai, Hao, Kang Chen, Melanie Arzigian, & Zack Z. Wang. (2008). Sequential roles of BMP-4, VEGF and FGF-2 in generation of CD34+ vascular progenitor cells from human embryonic stem cells under animal product-free condition. Cell Research. 18(S1). S108–S108. 3 indexed citations
5.
Wang, Zack Z., Hao Bai, Melanie Arzigian, Yongxing Gao, & Wenshu Wu. (2008). BMP4 and TGFbeta Differentially Regulate CD34+ Progenitor Development in Human Embryonic Stem Cells through SMAD-Dependent Pathway. Blood. 112(11). 889–889. 1 indexed citations
6.
Wang, Zack Z., Patrick Au, Tong Chen, et al.. (2007). Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nature Biotechnology. 25(3). 317–318. 224 indexed citations
7.
Chen, Tong, Hao Bai, Ying Shao, et al.. (2006). Stromal Cell-Derived Factor-1/CXCR4 Signaling Modifies the Capillary-Like Organization of Human Embryonic Stem Cell-Derived Endothelium In Vitro. Stem Cells. 25(2). 392–401. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026